These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 30938215
1. Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease. Alphandéry E. Nanotoxicology; 2019 Jun; 13(5):573-596. PubMed ID: 30938215 [Abstract] [Full Text] [Related]
2. Bio-synthesized iron oxide nanoparticles for cancer treatment. Alphandéry E. Int J Pharm; 2020 Aug 30; 586():119472. PubMed ID: 32590095 [Abstract] [Full Text] [Related]
3. The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging. Choi WI, Kim JY, Heo SU, Jeong YY, Kim YH, Tae G. J Control Release; 2012 Sep 10; 162(2):267-75. PubMed ID: 22824783 [Abstract] [Full Text] [Related]
4. Targeting tumor cells using magnetic nanoparticles - a feasibility study in animal models. Goren K, Neelam N, Yuval JB, Weiss DJ, Kunicher N, Margel S, Mintz Y. Minim Invasive Ther Allied Technol; 2022 Oct 10; 31(7):1086-1095. PubMed ID: 36148547 [Abstract] [Full Text] [Related]
5. Biodistribution and histological analysis of iron oxide-dextran nanoparticles in wistar rats. Hannon G, Bogdanska A, Keogh A, Finn SP, Gobbo OL, Prina-Mello A. Nanotoxicology; 2023 Dec 10; 17(8-9):562-580. PubMed ID: 37982374 [Abstract] [Full Text] [Related]
6. Mitoxantrone-iron oxide biodistribution in blood, tumor, spleen, and liver--magnetic nanoparticles in cancer treatment. Krukemeyer MG, Krenn V, Jakobs M, Wagner W. J Surg Res; 2012 Jun 01; 175(1):35-43. PubMed ID: 21470623 [Abstract] [Full Text] [Related]
7. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration. Aboushoushah S, Alshammari W, Darwesh R, Elbaily N. Life Sci; 2021 Jul 15; 277():119625. PubMed ID: 34015288 [Abstract] [Full Text] [Related]
8. Magnetic nanoparticles-loaded liposomes as a novel treatment agent for iron deficiency anemia: In vivo study. Fathy MM, Fahmy HM, Balah AMM, Mohamed FF, Elshemey WM. Life Sci; 2019 Oct 01; 234():116787. PubMed ID: 31445028 [Abstract] [Full Text] [Related]
14. Tumor cell targeting by iron oxide nanoparticles is dominated by different factors in vitro versus in vivo. NDong C, Tate JA, Kett WC, Batra J, Demidenko E, Lewis LD, Hoopes PJ, Gerngross TU, Griswold KE. PLoS One; 2015 Aug 26; 10(2):e0115636. PubMed ID: 25695795 [Abstract] [Full Text] [Related]
18. Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment. Petryk A, Giustini A, Ryan P, Strawbridge R, Hoopes P. Proc SPIE Int Soc Opt Eng; 2009 Feb 23; 7181():71810N. PubMed ID: 25346581 [Abstract] [Full Text] [Related]
19. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. Miller-Kleinhenz J, Guo X, Qian W, Zhou H, Bozeman EN, Zhu L, Ji X, Wang YA, Styblo T, O'Regan R, Mao H, Yang L. Biomaterials; 2018 Jan 23; 152():47-62. PubMed ID: 29107218 [Abstract] [Full Text] [Related]